Structural basis for the inhibition of Aurora A kinase by a novel class of high affinity disubstituted pyrimidine inhibitorsLeslie W. Tari, Ronald V. Swanson, Isaac Hoffman et al.|Bioorganic & Medicinal Chemistry Letters|2006Cited by 37
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinomaLove Goyal, D.C. Bensen, E. Wehrenberg-Klee et al.|Annals of Oncology|2024Cited by 33
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and AchondroplasiaRobert L. Hudkins, Daniel C. Bensen, Isaac Hoffman et al.|Journal of Medicinal Chemistry|2024Cited by 28
Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance MutationsRobert L. Hudkins, Daniel C. Bensen, Samhita Iyer et al.|Journal of Medicinal Chemistry|2026Cited by 0